beloranib

beloranib
Trade Name
Orphan Indication Prader-Willi syndrome
USA Market Approval USA
USA Designation Date 2013-01-15 00:00:00
Sponsor Zafgen, Inc.;175 Portland Street, 4th Floor;Boston, Massachusetts, 02114